printer version
Presentation Schedule
View the Complete Presentation Schedule
| Tuesday, November 18, 2003 |
| 2:20 PM | 204A |
Triad Therapeutics, Inc. |
Autoimmune/Inflammation |
| 2:20 PM | 204C |
Aptamera, Inc. |
Cancer |
| 2:30 PM | 204A |
Merrimack Pharmaceuticals, Inc. |
Autoimmune/Inflammation |
| 2:30 PM | 204C |
Targeted Diagnostics & Therapeutics, Inc. |
Cancer |
| 2:40 PM | 204A |
Phenomix Corporation |
Autoimmune/Inflammation |
| 2:40 PM | 204C |
Celator Technologies Inc. |
Cancer |
| 2:50 PM | 204A |
CombinatoRx |
Drug Discovery |
| 2:50 PM | 204C |
PBL Therapeutics |
Cancer |
| 3:00 PM | 204A |
Structural GenomiX, Inc. |
Drug Discovery |
| 3:00 PM | 204C |
Onconova Therapeutics Inc. |
Cancer |
| 3:10 PM | 204A |
Locus Pharmaceuticals, Inc. |
Drug Discovery |
| 3:10 PM | 204C |
Rejuvenon Corp. |
Cancer |
| 3:20 PM | 204A |
Norak Biosciences, Inc. |
Drug Discovery |
| 3:20 PM | 204C |
Alteris Therapeutics, Inc. |
Cancer |
| 3:30 PM | 204A |
Gryphon Therapeutics, Inc. |
Drug Discovery |
| 3:30 PM | 204C |
Bonecraft LLC |
Musculoskeletal |
| 3:40 PM | 204A |
Scion Pharmaceuticals Inc. |
Drug Discovery |
| 3:40 PM | 204C |
Cytokine PharmaSciences Inc. |
Autoimmune/Inflammation |
| 3:50 PM | 204A |
Hydra Biosciences, Inc. |
Cardiovascular |
| 3:50 PM | 204C |
ImmunoSite, Inc. |
Autoimmune/Inflammation |
| 4:00 PM | 204A |
Cardiokine Inc. |
Cardiovascular |
| 4:00 PM | 204C |
PhysioAdvantage LLC |
Pulmonary |
|